Subscribe
shutterstock-135807482-roche-1
lucarista / shutterstock.com
13 July 2021MedtechAlex Baldwin

English court says Roche did not infringe insulin pump patents

The  English High Court has cleared  Roche of patent infringement claims over its line of insulin pumps but shot down the pharma giant’s attempt to invalidate the plaintiff’s patent.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Swiss big pharma settles patent dispute with Insulet
12 July 2022   The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.
Big Pharma
Roche and Bluebird settle ‘Spark’ TM suit
19 May 2022   Roche subsidiary Spark Therapeutics has settled a lawsuit with rival gene-therapy company Bluebird Bio, which it had accused of infringing its “Spark” trademarks when marketing treatment for sickle-cell disease.
Big Pharma
Roche asks court for halt of Novartis unit’s generic launch
4 April 2022   Roche’s subsidiary Genentech has asked a Delaware court to block two of Novartis’ units from selling a generic version of the blockbuster lung-disease drug Esbriet.


Editor's picks

Smart ringleader: Could Ōura’s market dominance be under threat?
Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025

Editor's picks

Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025

More on this story

Americas
Swiss big pharma settles patent dispute with Insulet
12 July 2022   The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.
Big Pharma
Roche and Bluebird settle ‘Spark’ TM suit
19 May 2022   Roche subsidiary Spark Therapeutics has settled a lawsuit with rival gene-therapy company Bluebird Bio, which it had accused of infringing its “Spark” trademarks when marketing treatment for sickle-cell disease.
Big Pharma
Roche asks court for halt of Novartis unit’s generic launch
4 April 2022   Roche’s subsidiary Genentech has asked a Delaware court to block two of Novartis’ units from selling a generic version of the blockbuster lung-disease drug Esbriet.

More on this story

Americas
Swiss big pharma settles patent dispute with Insulet
12 July 2022   The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.
Big Pharma
Roche and Bluebird settle ‘Spark’ TM suit
19 May 2022   Roche subsidiary Spark Therapeutics has settled a lawsuit with rival gene-therapy company Bluebird Bio, which it had accused of infringing its “Spark” trademarks when marketing treatment for sickle-cell disease.
Big Pharma
Roche asks court for halt of Novartis unit’s generic launch
4 April 2022   Roche’s subsidiary Genentech has asked a Delaware court to block two of Novartis’ units from selling a generic version of the blockbuster lung-disease drug Esbriet.

More features

GSK escalates mRNA COVID-19 vaccine dispute
Smart ringleader: Could Ōura’s market dominance be under threat?
The flaw that landed Sanofi a win in the rare disease space
Roche resolves cancer test dispute with Stanford affiliated startup
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
UK firm expands in Germany with more litigation hires
Sandoz blocked by UK court from seeking Xarelto profits
The rise of pro-NPE and patent sentiment in the US